Consolidation! Dyadic sells industrial technology biz to DuPont for $75M
As Dyadic cashes out of industrial biotech and retains a C1 license for pharma, DSM and Syngenta also announce a partnership. Companies are girding their loins for the long haul. The Digest takes a look, In Florida, DuPont Industrial Biosciences will acquire substantially all of the enzyme and technology assets Dyadic’s Industrial Technology business for $75 […]














